AI assistant
Sending…
UNIVERSAL TECHNICAL INSTITUTE INC — Director's Dealing 2010
Mar 8, 2010
31931_dirs_2010-03-08_6b1d4ce4-2f9e-4fb7-96f5-fbbd29b60274.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNIVERSAL TECHNICAL INSTITUTE INC (UTI)
CIK: 0001261654
Period of Report: 2010-03-05
Reporting Person: Crain Richard (Sr. VP of Marketing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-05 | Common Stock, $0.0001 par value | M | 5225 | $12.75 | Acquired | 24520 | Direct |
| 2010-03-05 | Common Stock, $0.0001 par value | M | 1223 | $11.41 | Acquired | 25743 | Direct |
| 2010-03-05 | Common Stock, $0.0001 par value | S | 1742 | $25.759 | Disposed | 24001 | Direct |
| 2010-03-05 | Common Stock, $0.0001 par value | S | 5225 | $25.817 | Disposed | 18776 | Direct |
| 2010-03-05 | Common Stock, $0.0001 par value | S | 1223 | $25.899 | Disposed | 17553 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-05 | Employee Stock Option (Right To Buy) | $11.41 | M | 1223 | Disposed | 2016-02-25 | Common Stock, $0.0001 par value (1223) | Direct |
| 2010-03-05 | Employee Stock Option (Right To Buy) | $12.75 | M | 5225 | Disposed | 2015-06-03 | Common Stock, $0.0001 par value (5225) | Direct |
Footnotes
F1: Listed price is based on an average stock price with the price ranging between $25.75 - $25.76.
F2: Listed price is based on an average stock price with the price ranging between $25.70 - $25.94.
F3: Listed price is based on an average stock price with the price ranging between $25.87 - $25.91.
More from UNIVERSAL TECHNICAL INSTITUTE INC
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 17
Interim / Quarterly Report
2026
Feb 5
Regulatory Filings
2026
Feb 4
Director's Dealing
2026
Jan 21
Annual Report
2026
Jan 20